| Patient | Ray Charles |
|---|---|
| Date of birth | 1930-09-23 |
| Identifiers | MRN HR-ML009-SYN-TD; SSN (made up) 000-09-5561 |
| Document date | 1996-09-01 |
| Author | Gloria Fenwick, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Six-month review with depression screening and the plan for any future pain. [S]
Mr. Charles returns six months after his first visit. He has had no opioid or other drug use and no cravings. His mood is good, and he answered the PHQ-9 aloud today with a score of 2, with no thoughts of suicide or self-harm. His eyes have been comfortable. He has had no falls. The naloxone sprays are in date. He finished the written plan for any future pain with Dr. Fenwick today and has it saved on his phone. [S]
| Element | Detail |
|---|---|
| Recovery | Sustained remission; no cravings |
| Mood | PHQ-9 2; item 9 scored 0 |
| Pain plan | Finished and saved on his phone |
| Falls | None in six months |
| System | Result | Finding |
|---|---|---|
| Eyes | Negative | No eye pain, redness, or discharge |
| Psychiatric | Negative | Mood good; no cravings; no thoughts of suicide or self-harm; PHQ-9 score 2 |
| Musculoskeletal | Negative | No falls or pain |
3 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Naloxone 4 mg nasal spray, one spray in one nostril for a suspected opioid overdose; may repeat every 2 to 3 minutes in alternating nostrils | One spray (4 mg) in one nostril for suspected overdose; repeat every 2 to 3 minutes if there is no response, and call 911 | Nasal route | 1996-03-03 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1996-09-01 | Body height | 178 | cm | S |
| 1996-09-01 | Body weight | 80 | kg | S |
| 1996-09-01 | Body mass index (BMI) [Ratio] | 25.2 | kg/m2 | S |
| 1996-09-01 | Systolic blood pressure | 128 | mm[Hg] | S |
| 1996-09-01 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1996-09-01 | Heart rate | 66 | /min | S |
| 1996-09-01 | Respiratory rate | 14 | /min | S |
| 1996-09-01 | Body temperature | 36.6 | Cel | S |
| 1996-09-01 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1996-09-01 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 2 | {score} | S |
Vital signs recorded on 1996-09-01; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Alert, warm, and engaged |
| Eyes | No light perception; lids and ocular surfaces quiet |
| Psychiatric | Euthymic; organized thought; no signs of intoxication or withdrawal |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Blindness of both eyes since childhood, no light perception; cause never diagnosed | active | confirmed | H54.0X55 | S — Synthetic modern coding of the documented childhood blindness; category 5 (no light perception) is a synthetic grading of what the sources call blindness. |
| Opioid use disorder (heroin), in sustained remission for more than thirty years, without medication treatment | active | confirmed | F11.21 | S — Synthetic modern coding of the publicly admitted heroin addiction and his documented recovery; listed as an active problem because it is managed at every visit, with remission carried by the code. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Eye comfort and ocular surface check: pain, redness, discharge | Every visit | Completed today | No pain, redness, or discharge |
| Examination | Tonometry (eye pressure) | Every glaucoma visit; for blind eyes, only if pain or redness | Not indicated | Painless blind eyes, as advised by ophthalmology |
| Examination | Comprehensive eye examination | Yearly for blind eyes, or with symptoms | Up to date | Ophthalmology examination five months ago; next in the spring |
| Survey | Depression screen (PHQ-9) | At intake, at six months, and yearly | Completed today | PHQ-9 2, read aloud, with item 9 scored 0 |
| Survey | Suicide-risk review and safety plan, with the 988 Suicide & Crisis Lifeline | Every visit | Completed today | No thoughts of suicide or self-harm; the 988 Suicide & Crisis Lifeline still saved in his phone |
| Self-management | Recovery check: any return to use, cravings, triggers, and supports | Every visit | Completed today | No return to use and no cravings |
| Medication safety | Naloxone at home and when traveling | At intake; check expiry at each visit | Completed today | Both sprays in date |
| Survey | Drug-use screen (DAST-10) | Yearly | Up to date | DAST-10 0 six months ago; next at the annual wellness visit |
| Survey | Alcohol screen (AUDIT-C) | Yearly | Up to date | AUDIT-C 2 six months ago; next at the annual wellness visit |
| Laboratory | Hepatitis C, hepatitis B, and HIV testing | At entry to care for a person with a substance use disorder | Due | At the annual wellness visit next month |
| Self-management | Written plan for any future acute pain or surgery | Before any planned procedure, and once in remission | Completed today | Finished today and saved in an accessible format on his phone |
| Self-management | Accessible documents and communication | Every visit | Completed today | Pain plan and visit summary sent as accessible documents |
| Medication safety | Medicine labeling in braille or audio | With every new prescription | Up to date | No new prescriptions |
| Examination | CDC STEADI fall-risk screen | Every visit from age 65 | Completed today | No falls in six months |
| Self-management | Advance care planning | Yearly from age 65 | Due | At the annual wellness visit next month |
| Self-management | Vaccinations | Yearly, per the CDC schedule | Due | Influenza and pneumococcal vaccines at the annual wellness visit next month |
Goal progress:
Guideline basis: VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders (2021); The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update (2020); Primary Open-Angle Glaucoma Preferred Practice Pattern (2025); Vision Rehabilitation Preferred Practice Pattern (2023); Depression and Suicide Risk in Adults: Screening (2023); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, glaucoma and depression, bipolar, and mood disorders monographs (2026)
Follow-up: Annual wellness visit in five weeks, with the hepatitis and HIV tests, vaccines, and advance care planning. Next scheduled visit 1996-10-06: subsequent annual wellness visit. [S]